171 related articles for article (PubMed ID: 23866835)
1. 'Huang Qi Elixir' for proteinuria in patients with diabetic nephropathy: a study protocol for a randomized controlled pilot trial.
Tu X; Liu F; Jordan JB; Ye XF; Fu P; Wang F; Zhong S
Trials; 2013 Jul; 14():223. PubMed ID: 23866835
[TBL] [Abstract][Full Text] [Related]
2. The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial.
Wang H; Mu W; Zhai J; Xing D; Miao S; Wang J; Deng Y; Wang N; Chen H; Yang H; He X; Shang H
Trials; 2013 Jun; 14():165. PubMed ID: 23738508
[TBL] [Abstract][Full Text] [Related]
3. Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial.
Zhao XM; Zhang Y; He XH; Chen HD; Wang ZF; Guo J; Wang XM; Gao ZZ; Wang JP; Liu W; Zhao LH; Tong XL
Trials; 2018 Mar; 19(1):200. PubMed ID: 29587863
[TBL] [Abstract][Full Text] [Related]
4. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
Yan M; Wen Y; Yang L; Wu X; Lu X; Zhang B; Huang W; Li P
Trials; 2016 May; 17(1):259. PubMed ID: 27216240
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial.
Kou J; Wu J; Yang HT; He YN; Fang JA; Deng YY; Xie YS; Nie LF; Lin HL; Cai GY; Chen XM
Trials; 2014 Dec; 15():479. PubMed ID: 25480673
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: a multicenter double-blinded randomized placebo-controlled trial.
Li P; Chen Y; Liu J; Hong J; Deng Y; Yang F; Jin X; Gao J; Li J; Fang H; Liu G; Shi L; Du J; Li Y; Yan M; Wen Y; Yang W
PLoS One; 2015; 10(5):e0126027. PubMed ID: 25938778
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis.
Lin YQ; Yu F; Chen HJ; Deng YR; Lin J; Xu Y; Zheng X; Zhang JW; Liu JF
Ren Fail; 2024 Dec; 46(2):2359033. PubMed ID: 38836372
[TBL] [Abstract][Full Text] [Related]
8. Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial.
Jin D; Huang WJ; Meng X; Yang F; Bao Q; Zhang MZ; Yang YN; Ni Q; Lian FM; Tong XL
Trials; 2019 Dec; 20(1):756. PubMed ID: 31864393
[TBL] [Abstract][Full Text] [Related]
9. Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial.
Chan KW; Ip TP; Kwong AS; Lui SL; Chan GC; Cowling BJ; Yiu WH; Wong DW; Liu Y; Feng Y; Tan KC; Chan LY; Leung JC; Lai KN; Tang SC
BMJ Open; 2016 Aug; 6(8):e010741. PubMed ID: 27496229
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan.
Wei Y; Huang YS; Yang Z; Wang X; Li Y; Zhang Y; Zhao LH; Tong X
Trials; 2022 Jan; 23(1):61. PubMed ID: 35057843
[TBL] [Abstract][Full Text] [Related]
11. Effects of Keluoxin capsule combined with losartan potassium on diabetic kidney disease: study protocol for a randomized double-blind placebo-controlled multicenter clinical trial.
Wu R; Wei F; Qu L; Bai L; Li J; Li F; Yan W; Wang Q; Wei J
Trials; 2020 Nov; 21(1):951. PubMed ID: 33228726
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of astragalus injection combined with Western medicine in the treatment of early diabetic nephropathy: A protocol for systematic review and meta-analysis.
Li G; Ai B; Zhang W; Feng X; Jiang M
Medicine (Baltimore); 2021 Mar; 100(12):e25096. PubMed ID: 33761672
[TBL] [Abstract][Full Text] [Related]
13. Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial.
Liu M; Di YM; Zhang L; Yang L; Zhang L; Chen J; Wang R; Xie X; Lan F; Xie L; Huang J; Zhang AL; Xue CC; Liu X
Front Endocrinol (Lausanne); 2024; 15():1334609. PubMed ID: 38390199
[TBL] [Abstract][Full Text] [Related]
14. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.
Wang M; Wang Z; Zhou J; Sun W; Wang Y; Han M; Yang H; Liu WJ; Wang Y
Trials; 2018 Jul; 19(1):389. PubMed ID: 30016983
[TBL] [Abstract][Full Text] [Related]
15. Yuquan pill enhance the effect of Western medicine in treatment diabetic nephropathy: A protocol for systematic review and meta-analysis.
Liu L; Zhang Y; Zhu Z; Yu Z; Bao P; Nan Z
Medicine (Baltimore); 2021 Oct; 100(42):e27555. PubMed ID: 34678893
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
[TBL] [Abstract][Full Text] [Related]
17. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Kolkhof P; Joseph A; Pieper A; Kimmeskamp-Kirschbaum N; Ruilope LM;
JAMA; 2015 Sep; 314(9):884-94. PubMed ID: 26325557
[TBL] [Abstract][Full Text] [Related]
18.
Lengnan X; Ban Z; Haitao W; Lili L; Aiqun C; Huan W; Ping Z; Yonghui M
Biomed Res Int; 2020; 2020():9181037. PubMed ID: 32596393
[TBL] [Abstract][Full Text] [Related]
19. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled clinical trial study protocol of Liuwei Dihuang pills in the adjuvant treatment of diabetic kidney disease.
Liao T; Zhao K; Huang Q; Tang S; Chen K; Xie C; Zhang C; Gan W
Medicine (Baltimore); 2020 Jul; 99(31):e21137. PubMed ID: 32756091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
